Aliana Potter joined Blue Matter as a Consultant in 2026 bringing policy expertise spanning oncology, immunology, vaccines, and HIV. Prior to joining Blue Matter, she advised biopharma clients on US federal and state drug pricing policy and market access at Avalere Health. Her earlier experience includes a US policy role at Moderna and academic research in the healthcare space. Aliana holds a BA in Public Health from Hamilton College.